Harbin Gloria Pharmaceuticals News

Yuheng Pharmaceutical (002437): Rich product pipeline and gradual recovery in performance

TianfengDec 29, 2024 20:57

Yuheng Pharmaceutical (002437) Interim Report Review: Slowing Performance Growth Lays Out in the Chronic Disease and Biopharmaceutical Sectors

銀河證券Aug 30, 2016 00:00

[Galaxy Securities] Yu Heng Pharmaceutical report comments: slow performance growth, layout of chronic diseases and biomedicine areas

銀河證券Aug 29, 2016 00:00

Comments on Yuheng Pharmaceutical (002437) Annual report: M & A drives High performance and pays attention to Industrial layout

興業證券Apr 22, 2016 00:00

[Cinda Securities] Yu Heng Pharmaceutical Industry: pharmaceutical Industry

信達證券Apr 5, 2016 00:00

[Cinda Securities] Yu Heng Pharmaceutical Industry: pharmaceutical Industry

信達證券Mar 28, 2016 00:00

[Cinda Securities] Yu Heng Pharmaceutical Industry: pharmaceutical Industry

信達證券Mar 21, 2016 00:00

In-depth study of Yu Heng Pharmaceutical Industry (002437): epitaxial mergers and acquisitions promote High growth

東興證券Nov 25, 2015 00:00

Yu Heng Pharmaceutical Co., Ltd. (002437) 2015 three-quarter report and fixed increase announcement comments: the landing of the strategy of high growth and fixed increase of creatine phosphate.

國泰君安Oct 27, 2015 00:00

Yu Heng Pharmaceutical (002437) report comments: second-tier varieties achieve high growth and actively distribute the field of medical services and financial services

銀河證券Aug 28, 2015 00:00

[Societe Generale Securities] Yu Heng Pharmaceutical Co., Ltd.: high growth in extension and perfect product layout

興業證券Aug 26, 2015 00:00

誉衡药业(002437)中报点评：外延成就高增长 产品布局日趋完善

興業證券Aug 26, 2015 00:00

【国泰君安证券】誉衡药业:迈出进军医疗服务第一步

國泰君安Jun 3, 2015 00:00

【广发证券】誉衡药业:意向收购民营医院,首次布局医疗服务

廣發證券Jun 3, 2015 00:00

【长江证券】誉衡药业:并购推动高增长,产品梯队日渐完善

長江證券Apr 27, 2015 00:00

[Guotai Junan Securities] Yuheng Pharmaceutical: The merger between the two companies has been completed, and we look forward to strong integration

國泰君安Apr 27, 2015 00:00

【招商证券】誉衡药业:1季度利润增速略超

招商證券Apr 27, 2015 00:00

【长江证券】誉衡药业:业绩高速增长,积极外延、转型

長江證券Apr 3, 2015 00:00

【招商证券】誉衡药业:多方面因素驱动,15年净利润仍将实现高速增长

招商證券Apr 3, 2015 00:00

【国泰君安证券】誉衡药业2014年报点评:外延并购继续,三大战略领域初定

國泰君安Apr 3, 2015 00:00